A panel of outside experts advising the US Centers for Disease Control and Prevention (CDC) on Wednesday voted to recommend booster shots of the Pfizer-BioNTech COVID-19 vaccine be made available to 12- to 15-year-olds, Reuters reports.
The CDC's Advisory Committee on Immunization Practices (ACIP) voted 13 to 1 to recommend that the US health agency support booster shots for those aged 12 to 15 at least five months after their second dose.